Skip to main content
. 2020 May 20;23(5):321–332. doi: 10.3779/j.issn.1009-3419.2020.104.02

4.

Analysis of Cox regression's survival for miR-222 serum expression variable (fold change) in advanced stage NSCLC with metastasis M1b

Variable Hazard ratio (HR) HR (95%CI) P
Serum miR-222 levels (n=19)
High (equal or more higher than median) (n=8) 0.44 (0.37-0.97) 0.049*
Low (less than median) (n=11) 1.00